Literature DB >> 7049453

Yeast opsonization in newborn infants and its relationship to parental atopy.

V F Richardson, V F Larcher, J F Price.   

Abstract

Sera from 30 of 303 (9.9%) unselected term newborn infants were deficient in their ability to opsonize heat-killed baker's yeasts, an incidence which is almost double that seen in adults. Genetic influence is important in some since the mothers of 10 infants with defective opsonization showed the same defect, but it was not related to the sex or race of the infant or to the atopic state of the parents. In others the defect could be due to a functional maturation delay of the complement system, but not to inhibitory factors in neonatal serum since correction of opsonization was achieved with subopsonizing amounts of normal sera. Significantly more infants had sera with high opsonizing capacity (greater than 80% yeasts phagocytosed) when compared with adults; perhaps antibody independent immune mechanisms like this are important in the newborn. This study shows that a common specific immunodeficiency which may predispose to severe infection or atopy can be identified at birth.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049453      PMCID: PMC1536474     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  The alternative pathway of complement activation in the neonate.

Authors:  P A Feinstein; S R Kaplan
Journal:  Pediatr Res       Date:  1975-10       Impact factor: 3.756

2.  Prevalence and familial association of atopic disease and its relationship to serum IgE levels in 1,061 school children and their families.

Authors:  K J Turner; D L Rosman; J O'Mahony
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

3.  Transient IgA deficiency and pathogenesis of infantile atopy.

Authors:  B Taylor; A P Norman; H A Orgel; C R Stokes; M W Turner; J F Soothill
Journal:  Lancet       Date:  1973-07-21       Impact factor: 79.321

4.  Fatal familial Leiner's disease: a deficiency of the opsonic activity of serum complement.

Authors:  J C Jacobs; M E Miller
Journal:  Pediatrics       Date:  1972-02       Impact factor: 7.124

5.  Impaired opsonic activity but normal phagocytosis in low-birth-weight infants.

Authors:  M L Forman; E R Stiehm
Journal:  N Engl J Med       Date:  1969-10-23       Impact factor: 91.245

6.  A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5).

Authors:  M E Miller; U R Nilsson
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

7.  Leukocyte function and the development of opsonic and complement activity in the neonate.

Authors:  G H McCracken; H F Eichenwald
Journal:  Am J Dis Child       Date:  1971-02

8.  Familial opsonization defect associated with fatal infantile dermatitis, infections, and histiocytosis.

Authors:  H Scott; E J Moynahan; R A Risdon; B A Harvey; J F Soothill
Journal:  Arch Dis Child       Date:  1975-04       Impact factor: 3.791

9.  Immunoglobulin deficiencies in an atopic population.

Authors:  H S Kaufman; J R Hobbs
Journal:  Lancet       Date:  1970-11-21       Impact factor: 79.321

10.  The prevalence of immediate positive skin tests to Dermatophagoides pteronyssinus and grass pollen in schoolchildren.

Authors:  R C Godfrey; M Griffiths
Journal:  Clin Allergy       Date:  1976-01
View more
  3 in total

1.  The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations.

Authors:  M Super; R J Levinsky; M W Turner
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

2.  Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity.

Authors:  M W Turner; N D Seymour; M D Kazatchkine; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

3.  Decreased opsonic activity for Staphylococcus aureus in neonatal and late gestation maternal sera.

Authors:  P E Sebring; J G Bender; D E Van Epps
Journal:  Inflammation       Date:  1989-10       Impact factor: 4.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.